Coltman Ca
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 9
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Von Hoff (5 shared papers)Donna Stock-Novack (2 shared papers)John Crowley (2 shared papers)BG Durie (2 shared papers)SE Salmon (2 shared papers)Patrick R. Finley (2 shared papers)Jones Se (5 shared papers)B Forseth (1 shared paper)
- Journals
- Blood (2 papers)PubMed (23 papers)
- Partner nations
- United States
In The Last Decade
Coltman Ca
25 papers receiving 805 citations
Peers
Comparison fields: 5 of 68
- Hematology 301
- Pathology and Forensic Medicine 231
- Oncology 354
- Genetics 113
- Otorhinolaryngology 31
Countries citing papers authored by Coltman Ca
This map shows the geographic impact of Coltman Ca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coltman Ca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coltman Ca more than expected).
Fields of papers citing papers by Coltman Ca
This network shows the impact of papers produced by Coltman Ca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coltman Ca. The network helps show where Coltman Ca may publish in the future.
Co-authors
The 25 scholars most cited alongside Coltman Ca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. | 1982 | 145 |
| 2 | 1990 | 134 | |
| 3 | 1990 | 126 | |
| 4 | Activity of mitoxantrone in a human tumor cloning system. | 1981 | 79 |
| 5 | Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study. | 1987 | 52 |
| 6 | Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group. | 1977 | 48 |
| 7 | Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study. | 1979 | 37 |
| 8 | Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancer. | 1976 | 31 |
| 9 | Mitoxantrone in refractory nonHodgkin's lymphoma. A Southwest Oncology Group study. | 1984 | 31 |
| 10 | Evaluation of VP-16-213 in malignant lymphoma and melanoma. | 1978 | 29 |
| 11 | Evaluation of single-agent cisplatin in the management of non-small cell carcinoma of the lung: a Southwest Oncology Group Study. | 1983 | 25 |
| 12 | Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung. | 1981 | 24 |
| 13 | Conclusions from clinical trials of the Southwest Oncology Group. | 1982 | 22 |
| 14 | Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance. | 1992 | 22 |
| 15 | Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study. | 1980 | 19 |
| 16 | Vinblastine (NSC-49842) and bleomycin (NSC-125066) therapy for disseminated testicular tumors. | 1974 | 17 |
| 17 | Candidal abscess of the spleen in patients with acute leukemia. | 1980 | 16 |
| 18 | Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study. | 1987 | 11 |
| 19 | Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study. | 1983 | 8 |
| 20 | Sweat collection in cystic fibrosis. Report of a simplified method employing pilocarpine iontophoresis and cellulose sponge. | 1962 | 7 |
About Coltman Ca
Coltman Ca is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Pathology and Forensic Medicine and Molecular Biology, having authored 25 papers that have together received 898 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Lymphoma Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers), Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Hematology (301 citations), Pathology and Forensic Medicine (231 citations), Oncology (354 citations), Genetics (113 citations) and Otorhinolaryngology (31 citations). Coltman Ca has collaborated with scholars based in United States. Frequent co-authors include Von Hoff, Donna Stock-Novack, John Crowley, BG Durie, SE Salmon, Patrick R. Finley, Jones Se, B Forseth, Muhyi Al‐Sarraf and Balcerzak Sp. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.